Search

everythinglearnresearchcommunity

for

Search:↓

Men born very underweight had higher estrogen levels but normal reproduction compared to normal birth weight men.

Hormonal changes during the reproductive cycle may cause seasonal skin problems in captive female fossas.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

Girls conceived via assisted reproductive technologies show early puberty signs and larger ovaries.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Giving melatonin to sheep before the non-breeding season can improve their chances of reproducing in northwest Mexico.

Melatonin improved sheep reproduction, being more beneficial and cost-effective in males.

Prairie dogs with fewer neighbors are more stressed but their number of babies isn't affected.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Women with menstrual dysfunction often have deficiencies in magnesium, iron, and vitamin D.

Older men have different fertility histories and factors affecting fertility, suggesting they may benefit from earlier fertility evaluations.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Finasteride reduces fertility in male rats.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Women with different PCOS types have similar fertility treatment results.

Finasteride does not negatively affect male reproductive function.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Lifestyle changes improve reproductive function and hormonal balance in obese women with PCOS.